Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01004861
Title Safety Study of PLX108-01 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications

Advanced Solid Tumor

Therapies

Pexidartinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.